KAZIA LAUNCHES NEW SCIENTIFIC ADVISORY BOARD COMPRISED OF WORLD-LEADING EXPERTS IN BRAIN CANCER

/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce the launch of its...

Related Keywords

Australia ,United States ,Sydney ,New South Wales ,Dana Farber Cancer Institute ,Massachusetts ,Stanford University ,California ,Boston ,Zurich ,Züsz ,Switzerland ,Houston ,Texas ,San Francisco ,American ,Swiss ,Karen Ferrante ,Murray Brennan ,Susang Komen ,James Garner ,Alan Olivero ,Patrick Wen ,Priscilla Brastianos ,Oncology Division ,University Of California ,Genentech ,Department Of Neurological Surgery ,Md Anderson Cancer Center ,Breast Cancer Research Foundation Award ,Society For Neuro ,Kazia Therapeutics Limited ,Central Nervous System Metastasis Center At Massachusetts ,Moonshot Program ,Johns Hopkins School Of Medicine ,Agents Selection Committee ,Kazia Therapeutics ,Dr John De Groot Is Division ,Hospital Harvard Medical School ,Swiss Federal Institute Of Technology ,Prnewswire Kazia Therapeutics Limited ,Genentech Inc ,College Of St ,Harvard Longwood Neurology Training Program ,University Of London ,American Association For Cancer Research ,Head Of Research Operations ,American Brain Tumor Association Joel Gingras Award ,Oncology At Dana Farber Cancer Institute ,Therapeutics Limited ,Scientific Advisory Board ,Professor Sir Murray Brennan ,Professor Peter Gunning ,Central Nervous System Metastasis Center ,Massachusetts General Hospital ,Johns Hopkins School ,Massachusetts General ,Central Nervous System Metastasis Clinic ,Harvard Medical ,Nextgen Star ,American Association ,Cancer Research ,Damon Runyon Clinical Investigator Award ,Career Catalyst Award ,Anne Klibanski Award ,John De Groot ,Division Chief ,Neuro Oncology Division ,Neurological Surgery ,Cancer Center ,Senior Director ,Discovery Chemistry ,Research Operations ,Swiss Federal Institute ,Harvard Medical School ,Dana Farber Cancer ,Response Assessment ,Working Group ,Medical College ,Neurologic Diseases ,Orphan Drug Designation ,Fast Track Designation ,Rare Pediatric Disease Designation ,Orphan Designation ,Annual Report ,Chief Executive Officer ,